LT3484907T - Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas - Google Patents
Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdasInfo
- Publication number
- LT3484907T LT3484907T LTEP17754482.2T LT17754482T LT3484907T LT 3484907 T LT3484907 T LT 3484907T LT 17754482 T LT17754482 T LT 17754482T LT 3484907 T LT3484907 T LT 3484907T
- Authority
- LT
- Lithuania
- Prior art keywords
- rna molecular
- phosphotriazole
- mrnr
- peptide
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL417980A PL417980A1 (pl) | 2016-07-16 | 2016-07-16 | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
PCT/IB2017/054221 WO2018015845A1 (en) | 2016-07-16 | 2017-07-12 | Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
LT3484907T true LT3484907T (lt) | 2020-09-10 |
Family
ID=59656110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP17754482.2T LT3484907T (lt) | 2016-07-16 | 2017-07-12 | Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas |
Country Status (14)
Country | Link |
---|---|
US (1) | US10696709B2 (lt) |
EP (1) | EP3484907B1 (lt) |
CY (1) | CY1123516T1 (lt) |
DK (1) | DK3484907T3 (lt) |
ES (1) | ES2820242T3 (lt) |
HR (1) | HRP20201274T1 (lt) |
HU (1) | HUE051312T2 (lt) |
LT (1) | LT3484907T (lt) |
PL (2) | PL417980A1 (lt) |
PT (1) | PT3484907T (lt) |
RS (1) | RS60848B1 (lt) |
SI (1) | SI3484907T1 (lt) |
SM (1) | SMT202000583T1 (lt) |
WO (1) | WO2018015845A1 (lt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016146143A1 (en) | 2015-03-16 | 2016-09-22 | Amal Therapeutics Sa | Cell penetrating peptides and complexes comprising the same |
LT3429618T (lt) | 2016-03-16 | 2024-05-10 | Amal Therapeutics Sa | Imuninės sistemos patikros taško moduliatoriaus ir komplekso, apimančio į ląsteles prasiskverbiantį peptidą, krovinį ir tlr peptido agonistą, derinys, skirtas naudoti medicinoje |
IL265479B (en) | 2016-09-21 | 2022-09-01 | Amal Therapeutics Sa | Fusion comprising a cell penetrating peptide, a multi epitope and a tlr peptide agonist for treatment of cancer |
WO2023250528A1 (en) * | 2022-06-24 | 2023-12-28 | The Broad Institute, Inc. | Compositions and methods for preparing capped circular rna molecules |
EP4464713A1 (en) | 2023-05-18 | 2024-11-20 | Siec Badawcza Lukasiewicz - PORT Polski Osrodek Rozwoju Technologii | Circular rna analogs, preparation and application thereof |
WO2025043082A2 (en) | 2023-08-23 | 2025-02-27 | The Broad Institute, Inc. | Compositions and methods to improve rna properties using base, phosphodiester linkage, sugar backbone, and cap modifications |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013059475A1 (en) | 2011-10-18 | 2013-04-25 | Life Technologies Corporation | Alkynyl-derivatized cap analogs, preparation and uses thereof |
-
2016
- 2016-07-16 PL PL417980A patent/PL417980A1/pl unknown
-
2017
- 2017-07-12 LT LTEP17754482.2T patent/LT3484907T/lt unknown
- 2017-07-12 PT PT177544822T patent/PT3484907T/pt unknown
- 2017-07-12 SI SI201730371T patent/SI3484907T1/sl unknown
- 2017-07-12 WO PCT/IB2017/054221 patent/WO2018015845A1/en unknown
- 2017-07-12 US US16/318,126 patent/US10696709B2/en active Active
- 2017-07-12 DK DK17754482.2T patent/DK3484907T3/da active
- 2017-07-12 SM SM20200583T patent/SMT202000583T1/it unknown
- 2017-07-12 PL PL17754482T patent/PL3484907T3/pl unknown
- 2017-07-12 HU HUE17754482A patent/HUE051312T2/hu unknown
- 2017-07-12 RS RS20200968A patent/RS60848B1/sr unknown
- 2017-07-12 ES ES17754482T patent/ES2820242T3/es active Active
- 2017-07-12 EP EP17754482.2A patent/EP3484907B1/en active Active
-
2020
- 2020-08-13 HR HRP20201274TT patent/HRP20201274T1/hr unknown
- 2020-08-13 CY CY20201100762T patent/CY1123516T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
SMT202000583T1 (it) | 2020-11-10 |
HUE051312T2 (hu) | 2021-03-01 |
CY1123516T1 (el) | 2022-03-24 |
WO2018015845A1 (en) | 2018-01-25 |
EP3484907A1 (en) | 2019-05-22 |
US20200055891A1 (en) | 2020-02-20 |
ES2820242T3 (es) | 2021-04-20 |
SI3484907T1 (sl) | 2020-12-31 |
PT3484907T (pt) | 2020-09-17 |
PL3484907T3 (pl) | 2021-02-08 |
RS60848B1 (sr) | 2020-10-30 |
US10696709B2 (en) | 2020-06-30 |
HRP20201274T1 (hr) | 2020-12-11 |
PL417980A1 (pl) | 2018-01-29 |
EP3484907B1 (en) | 2020-05-13 |
DK3484907T3 (da) | 2020-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT3484907T (lt) | Nauji fosfotriazolo mrnr 5` galo cap analogai, juos apimanti kompozicija, juos turinti rnr molekulė, jų panaudojimas ir rnr molekulės, baltymų ar peptidų sintezės būdas | |
MX2022001755A (es) | Compuestos de dinucleotidos ciclicos y metodos de uso. | |
CY1123274T1 (el) | Αντισωματα εναντι-οχ40 και χρησεις αυτων | |
IL271389A (en) | Targeted non-viral dna insertions | |
EP3436588A4 (en) | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | |
WO2016170348A3 (en) | Sarna compositions and methods of use | |
HUE061174T2 (hu) | 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény | |
EA201990071A1 (ru) | Композиция пептидной вакцины | |
EP3429354A4 (en) | CONJUGATES OF VITAMIN B AND AMINO ACIDS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYLE RIBOSIDES DERIVATIVES THEREOF, AND PROCESSES FOR THEIR PREPARATION | |
WO2015168161A3 (en) | Multiplexed single cell gene expression analysis using template switch and tagmentation | |
DK3330259T3 (da) | 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne | |
MA54411A (fr) | Compositions contenant de l'ibrutinib | |
MX2020006510A (es) | Peptido novedoso. | |
DOP2016000202A (es) | Proteínas de fusión uti | |
EP3344061A4 (en) | PROTEINOUS PAVED FULL-UPS | |
SG11202106327QA (en) | Oligomeric nucleic acid molecule and application thereof | |
FR3041644B1 (fr) | Polypeptides cycliques, leur procede d'obtention et leur application en therapeutique | |
HK1257448A1 (zh) | 包含c-c基序趨化因子22(ccl22)或其片段的疫苗組合物 | |
EP3490978A4 (en) | SALTS OF 2, 6-DIMETHYLPYRIMIDONE DERIVATIVES AND THEIR USES | |
FR3044226B1 (fr) | Extrait alcoolique de parties aeriennes de solidago virgaurea subsp. alpestris, son procede d'obtention, et composition cosmetique ou dermatologique le contenant | |
EP3329928A4 (en) | Composition containing cyclic dipeptide and sweetening agent | |
WO2016011201A3 (en) | Epha4 cyclic peptide antagonists for neuroprotection and neural repair | |
EP3475418A4 (en) | TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS AND THEIR USE | |
IL270917A (en) | Recombinant ROBO2 proteins, preparations, methods and their use | |
EP3416975A4 (en) | NOVEL ALPHA CONOTOXIN PEPTIDES |